<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Medical Device Courses | Dkonara921 | Mentions</title>
	<link>https://medicaldevicecourses.com/members/dkonara921/activity/mentions/</link>
	<atom:link href="https://medicaldevicecourses.com/members/dkonara921/activity/mentions/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed mentioning Dkonara921.</description>
	<lastBuildDate>Sat, 16 May 2026 14:21:09 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">80b74f2113e846a644ca0aaf5b4111a0</guid>
				<title>hzy2 replied to the topic Right to Try Law in the forum Clinical Research Basics</title>
				<link>https://medicaldevicecourses.com/activity/p/8666/</link>
				<pubDate>Sun, 28 Oct 2018 04:21:58 -0400</pubDate>

									<content:encoded><![CDATA[<p>Right to try law allows terminally ill patients to have access to drugs that are not yet approved by the FDA. If all other treatments have been attempted and resulted in failure and there is a high chance that the patient will soon die, it makes perfect sense for them to want to approach experimental drugs as a last chance at survival. At that&hellip;<span class="activity-read-more" id="activity-read-more-8666"><a href="https://medicaldevicecourses.com/activity/p/8666/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>